BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Webb GJ, Marjot T, Cook JA, Aloman C, Armstrong MJ, Brenner EJ, Catana MA, Cargill T, Dhanasekaran R, García-Juárez I, Hagström H, Kennedy JM, Marshall A, Masson S, Mercer CJ, Perumalswami PV, Ruiz I, Thaker S, Ufere NN, Barnes E, Barritt AS 4th, Moon AM. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study. Lancet Gastroenterol Hepatol 2020;5:1008-16. [PMID: 32866433 DOI: 10.1016/S2468-1253(20)30271-5] [Cited by in Crossref: 77] [Cited by in F6Publishing: 47] [Article Influence: 38.5] [Reference Citation Analysis]
Number Citing Articles
1 Lu L, Feng P, Yu M, Chen M, Lin AJ, Chen JL, Yu LH. Current utilization of interferon alpha for the treatment of coronavirus disease 2019: a comprehensive review. Cytokine & Growth Factor Reviews 2022. [DOI: 10.1016/j.cytogfr.2022.01.001] [Reference Citation Analysis]
2 Tejedor-Tejada J, Fuentes-Valenzuela E, Alonso-Martin C, Almohalla-Alvarez C, Garcia-Pajares F. COVID-19 and short and medium-term outcomes in liver transplant patients: A spanish single-center case series. J Clin Exp Hepatol 2021. [PMID: 34092967 DOI: 10.1016/j.jceh.2021.05.009] [Reference Citation Analysis]
3 Heldman MR, Kates OS. COVID-19 in Solid Organ Transplant Recipients: a Review of the Current Literature. Curr Treat Options Infect Dis 2021;:1-16. [PMID: 34220357 DOI: 10.1007/s40506-021-00249-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Gaspar R, Castelo Branco C, Macedo G. Liver and COVID-19: From care of patients with liver diseases to liver injury. World J Hepatol 2021; 13(10): 1367-1377 [PMID: 34786172 DOI: 10.4254/wjh.v13.i10.1367] [Reference Citation Analysis]
5 Kullar R, Patel AP, Saab S. COVID-19 in Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:545-50. [PMID: 34447684 DOI: 10.14218/JCTH.2020.00098] [Reference Citation Analysis]
6 Mohseni M, Albus M, Kaminski A, Harrison MF. A Case of COVID-19 Re-Infection in a Liver Transplant Patient. Cureus 2021;13:e14916. [PMID: 34113522 DOI: 10.7759/cureus.14916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fonseca EA, Feier F, Pugliese R, Freitas AF, Porta G, Miura I, Baggio V, Kondo M, Benavides M, Vincenzi R, Roda K, Oliveira CV, Chapchap P, Seda-Neto J. Pediatric liver transplantation activity in a high-volume program during the COVID-19 pandemic in Brazil. Pediatr Transplant 2021;:e14112. [PMID: 34396644 DOI: 10.1111/petr.14112] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Timmermann L, Globke B, Lurje G, Schmelzle M, Schöning W, Öllinger R, Pratschke J, Eberspächer B, Drosten C, Hofmann J, Eurich D. Humoral Immune Response following SARS-CoV-2 Vaccination in Liver Transplant Recipients. Vaccines (Basel) 2021;9:1422. [PMID: 34960168 DOI: 10.3390/vaccines9121422] [Reference Citation Analysis]
9 Middleton P, Hsu C, Lythgoe MP. Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studies. BMJ Open Gastroenterol 2021;8:e000739. [PMID: 34675033 DOI: 10.1136/bmjgast-2021-000739] [Reference Citation Analysis]
10 Nickerson AM, Sobotka LA, Kelly SG. PRO: Liver Transplantation in the Times of COVID-19: "To Transplant or Not to Transplant". Clin Liver Dis (Hoboken) 2021. [PMID: 34518778 DOI: 10.1002/cld.1131] [Reference Citation Analysis]
11 Zhong P, Xu J, Yang D, Shen Y, Wang L, Feng Y, Du C, Song Y, Wu C, Hu X, Sun Y. COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduct Target Ther 2020;5:256. [PMID: 33139693 DOI: 10.1038/s41392-020-00373-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
12 Yadav DK, Adhikari VP, Ling Q, Liang T. Immunosuppressants in Liver Transplant Recipients With Coronavirus Disease 2019: Capability or Catastrophe?-A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:756922. [PMID: 34859012 DOI: 10.3389/fmed.2021.756922] [Reference Citation Analysis]
13 Du M, Yang DS, Liu M, Liu J. COVID-19 and Liver dysfunction: Epidemiology, Association and Potential Mechanisms. Clin Res Hepatol Gastroenterol 2021;:101793. [PMID: 34428501 DOI: 10.1016/j.clinre.2021.101793] [Reference Citation Analysis]
14 Pereira MR, Arcasoy S, Farr MA, Mohan S, Emond JC, Tsapepas DS, Shi Q, Purpura L, Uhlemann AC, Zucker J, Verna EC. Outcomes of COVID-19 in solid organ transplant recipients: A matched cohort study. Transpl Infect Dis 2021;:e13637. [PMID: 33993630 DOI: 10.1111/tid.13637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Choudhary NS, Dhampalwar S, Saraf N, Soin AS. Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation. J Clin Exp Hepatol 2021. [PMID: 33994708 DOI: 10.1016/j.jceh.2021.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Kulkarni AV, Tevethia HV, Premkumar M, Arab JP, Candia R, Kumar K, Kumar P, Sharma M, Rao PN, Reddy DN. Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis. EClinicalMedicine 2021;38:101025. [PMID: 34278287 DOI: 10.1016/j.eclinm.2021.101025] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
17 Mallet V, Beeker N, Bouam S, Sogni P, Pol S; Demosthenes research group. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020. J Hepatol 2021;75:848-55. [PMID: 33992699 DOI: 10.1016/j.jhep.2021.04.052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Gato S, Lucena-Valera A, Muñoz-Hernández R, Sousa JM, Romero-Gómez M, Ampuero J. Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World J Virol 2021; 10(6): 301-311 [PMID: 34909404 DOI: 10.5501/wjv.v10.i6.301] [Reference Citation Analysis]
19 Kose A, Toplu SA, Yalcinsoy M, Yakupogullari Y, Otlu B, Otan E, Aydin C, Yilmaz S, Bayindir Y. Clinical Characteristics and Outcomes of Liver Transplantation Recipients With COVID-19 Pneumonia. Transplant Proc 2021:S0041-1345(21)00448-6. [PMID: 34261580 DOI: 10.1016/j.transproceed.2021.06.027] [Reference Citation Analysis]
20 Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Aldana AJG, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu-Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Zazueta GM, Demirezer-Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Narro GC, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Reyes EC, Harputluoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Vargas NCE, Güzelbulut F, Garcia SR, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, N Assis D, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis. Liver Int 2021. [PMID: 34846800 DOI: 10.1111/liv.15121] [Reference Citation Analysis]
21 Bhurwal A, Minacapelli CD, Orosz E, Gupta K, Tait C, Dalal I, Zhang C, Zhao E, Rustgi VK. COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations . World J Gastroenterol 2021; 27(46): 7969-7981 [DOI: 10.3748/wjg.v27.i46.7969] [Reference Citation Analysis]
22 Beraldo RF, Marcondes MB, Dos Santos MNM, Grillo TG, Pires GBT, de Oliveira CV. COVID-19 in a Patient with Liver Cirrhosis. Am J Case Rep 2021;22:e929948. [PMID: 33686051 DOI: 10.12659/AJCR.929948] [Reference Citation Analysis]
23 Whitsett M, Ortiz V, Weinberg EM. CON: Liver Transplantation in the Times of COVID-19: Patients with COVID-19 Infection Should not Undergo Liver Transplantation. Clin Liver Dis (Hoboken) 2021;18:233-6. [PMID: 34840724 DOI: 10.1002/cld.1136] [Reference Citation Analysis]
24 Sandal S, Boyarsky BJ, Massie A, Chiang TP, Segev DL, Cantarovich M. Immunosuppression practices during the COVID-19 pandemic: A multinational survey study of transplant programs. Clin Transplant 2021;:e14376. [PMID: 34050961 DOI: 10.1111/ctr.14376] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Cococcia S, Lenti MV, Santacroce G, Achilli G, Borrelli de Andreis F, Di Sabatino A. Liver-spleen axis dysfunction in COVID-19. World J Gastroenterol 2021; 27(35): 5919-5931 [PMID: 34629809 DOI: 10.3748/wjg.v27.i35.5919] [Reference Citation Analysis]
26 Jefremow A, Neurath MF. SARS-CoV-2 Virus Manifestations in the Gastrointestinal Tract: Therapeutic Implications. Visc Med 2021;37:63-9. [PMID: 33693046 DOI: 10.1159/000513180] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Heimbach JK, Taner T. SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19. Lancet Gastroenterol Hepatol 2020;5:958-60. [PMID: 32956620 DOI: 10.1016/S2468-1253(20)30293-4] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 García-Juárez I, Campos-Murguía A, Tovar-Méndez VH, Gabutti A, Ruiz I. Unexpected better outcome in a liver transplant recipient with COVID-19: a beneficial effect of tacrolimus? Rev Gastroenterol Mex (Engl Ed) 2020;85:437-42. [PMID: 33032841 DOI: 10.1016/j.rgmx.2020.08.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Delman AM, Turner KM, Jones CR, Vaysburg DM, Silski LS, King C, Luckett K, Safdar K, Quillin RC 3rd, Shah SA. Keeping the lights on: Telehealth, testing, and 6-month outcomes for orthotopic liver transplantation during the COVID-19 pandemic. Surgery 2021;169:1519-24. [PMID: 33589248 DOI: 10.1016/j.surg.2020.12.044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Marjot T, Webb GJ, Barritt AS 4th, Moon AM, Stamataki Z, Wong VW, Barnes E. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol 2021;18:348-64. [PMID: 33692570 DOI: 10.1038/s41575-021-00426-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 27.0] [Reference Citation Analysis]
31 Cho JY, Lee YS, Kim SS, Song DS, Lee JH, Kim JH. Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline. Clin Mol Hepatol 2021;27:515-23. [PMID: 34530524 DOI: 10.3350/cmh.2021.0293] [Reference Citation Analysis]
32 Costantino A, Invernizzi F, Centorrino E, Vecchi M, Lampertico P, Donato MF. COVID-19 Vaccine Acceptance among Liver Transplant Recipients. Vaccines (Basel) 2021;9:1314. [PMID: 34835245 DOI: 10.3390/vaccines9111314] [Reference Citation Analysis]
33 Devaux CA, Melenotte C, Piercecchi-Marti MD, Delteil C, Raoult D. Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19? Front Med (Lausanne) 2021;8:663708. [PMID: 34552938 DOI: 10.3389/fmed.2021.663708] [Reference Citation Analysis]
34 Tavabie OD, Abeysekera KWM, Tranah TH, Nayagam JS, Aluvihare VR. COVID-19 and liver transplantation: the jury is still out. Lancet Gastroenterol Hepatol 2021;6:10-1. [PMID: 33137286 DOI: 10.1016/S2468-1253(20)30313-7] [Reference Citation Analysis]
35 Webb GJ, Marjot T, Barnes E, Barritt AS 4th, Moon AM. COVID-19 and liver transplantation: the jury is still out - Authors' reply. Lancet Gastroenterol Hepatol 2021;6:11. [PMID: 33137285 DOI: 10.1016/S2468-1253(20)30337-X] [Reference Citation Analysis]
36 Alberca RW, Benard G, Alberca GGF, Sato MN. SARS-CoV-2 infection in liver transplant recipients: A complex relationship. World J Gastroenterol 2021; 27(44): 7734-7738 [PMID: 34908810 DOI: 10.3748/wjg.v27.i44.7734] [Reference Citation Analysis]
37 Reuken PA, Albers S, Rauchfuss F, Strnad P, Settmacher U, Trautwein C, Stallmach A, Bruns T. Acceptance of SARS-CoV-2 vaccines by liver transplant recipients and candidates. Z Gastroenterol 2021;59:1288-96. [PMID: 34670294 DOI: 10.1055/a-1649-8568] [Reference Citation Analysis]
38 Heldman MR, Kates OS, Fisher CE, Limaye AP. Immunosuppression in solid organ transplant recipients with Covid-19: More data, but still complicated. Transpl Infect Dis 2021;23:e13650. [PMID: 34325492 DOI: 10.1111/tid.13650] [Reference Citation Analysis]
39 Kidson KM, Park J, Charles MK, Omar M, Krajden M, Wright AJ, Hussaini T, Kim PTW, Chung SW, Yoshida EM. Successful Liver Transplantation in a Patient With Acute COVID-19 Infection and Acute Liver Failure: A Case Report. Transplant Direct 2021;7:e747. [PMID: 34476292 DOI: 10.1097/TXD.0000000000001210] [Reference Citation Analysis]
40 Jaduan SS, Singh SA, Madan K, Gupta S. SARS-CoV-2 infection in Liver Transplant recipients - Immunosuppression is the silver lining? J Clin Exp Hepatol 2021. [PMID: 34305351 DOI: 10.1016/j.jceh.2021.07.005] [Reference Citation Analysis]
41 Gupta M, Manek G, Dombrowski K, Maiwall R. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World J Meta-Anal 2021; 9(6): 522-542 [DOI: 10.13105/wjma.v9.i6.522] [Reference Citation Analysis]
42 Gracia-Ramos AE, Jaquez-Quintana JO, Contreras-Omaña R, Auron M. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol 2021; 27(26): 3951-3970 [PMID: 34326607 DOI: 10.3748/wjg.v27.i26.3951] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Mao R, Rieder F, Ben-Horin S, Kaplan GG, Ng SC, Wong GL, Ghosh S, Chen MH. Implications of COVID-19 for patients with pre-existing digestive diseases: an update. Lancet Gastroenterol Hepatol. 2021;6:258-260. [PMID: 33539813 DOI: 10.1016/s2468-1253(21)00025-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Tavabie OD, Clough J. Gastroenterology 2021: from the heart of the COVID-19 pandemic. Frontline Gastroenterol 2021;12:249-51. [PMID: 33907619 DOI: 10.1136/flgastro-2021-101799] [Reference Citation Analysis]
45 Wang X, Lei J, Li Z, Yan L. Potential Effects of Coronaviruses on the Liver: An Update. Front Med (Lausanne) 2021;8:651658. [PMID: 34646834 DOI: 10.3389/fmed.2021.651658] [Reference Citation Analysis]
46 De Carlis R, Vella I, Incarbone N, Centonze L, Buscemi V, Lauterio A, De Carlis L. Impact of the COVID-19 pandemic on liver donation and transplantation: A review of the literature. World J Gastroenterol 2021; 27(10): 928-938 [PMID: 33776364 DOI: 10.3748/wjg.v27.i10.928] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
47 John BV, Deng Y, Khakoo NS, Taddei TH, Kaplan DE, Dahman B. Coronavirus Disease 2019 Vaccination Is Associated With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Death in Liver Transplant Recipients. Gastroenterology 2021:S0016-5085(21)03722-7. [PMID: 34758352 DOI: 10.1053/j.gastro.2021.11.001] [Reference Citation Analysis]
48 Signorello A, Lenci I, Milana M, Grassi G, Baiocchi L. COVID-19 in normal, diseased and transplanted liver. World J Gastroenterol 2021; 27(20): 2576-2585 [PMID: 34092976 DOI: 10.3748/wjg.v27.i20.2576] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Loinaz-Segurola C, Marcacuzco-Quinto A, Fernández-Ruiz M. Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects. World J Hepatol 2021; 13(10): 1299-1315 [PMID: 34786167 DOI: 10.4254/wjh.v13.i10.1299] [Reference Citation Analysis]
50 Neurath MF. COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34188251 DOI: 10.1038/s41575-021-00480-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Merli M, Pasulo L, Perricone G, Travi G, Rossotti R, Colombo VG, De Carlis R, Chiappetta S, Moioli MC, Minetti E, Frigerio M, De Carlis LG, Belli L, Fagiuoli S, Puoti M. Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients. J Infect 2021;82:414-51. [PMID: 33127455 DOI: 10.1016/j.jinf.2020.10.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Cai Y, Ye LP, Song YQ, Mao XL, Wang L, Jiang YZ, Que WT, Li SW. Liver injury in COVID-19: Detection, pathogenesis, and treatment. World J Gastroenterol 2021; 27(22): 3022-3036 [PMID: 34168405 DOI: 10.3748/wjg.v27.i22.3022] [Reference Citation Analysis]
53 Gupta R, Gupta J, Ammar H. Impact of COVID-19 on the outcomes of gastrointestinal surgery. Clin J Gastroenterol 2021;14:932-46. [PMID: 33928515 DOI: 10.1007/s12328-021-01424-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Mohamed DZ, Ghoneim MES, Abu-Risha SES, Abdelsalam RA, Farag MA. Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management. World J Gastroenterol 2021; 27(28): 4504-4535 [PMID: 34366621 DOI: 10.3748/wjg.v27.i28.4504] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Marjot T, Buescher G, Sebode M, Barnes E, Barritt AS 4th, Armstrong MJ, Baldelli L, Kennedy J, Mercer C, Ozga AK, Casar C, Schramm C;  contributing Members and Collaborators of ERN RARE-LIVER/COVID-Hep/SECURE-Cirrhosis; Moon AM, Webb GJ, Lohse AW. SARS-CoV-2 infection in patients with autoimmune hepatitis. J Hepatol. 2021;74:1335-1343. [PMID: 33508378 DOI: 10.1016/j.jhep.2021.01.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 17.0] [Reference Citation Analysis]
56 Ito T, Kenmochi T, Ota A, Kuramitsu K, Soyama A, Kinoshita O, Eguchi S, Yuzawa K, Egawa H. National survey on deceased donor organ transplantation during the COVID-19 pandemic in Japan. Surg Today 2021. [PMID: 34686930 DOI: 10.1007/s00595-021-02388-1] [Reference Citation Analysis]
57 Kehar M, Ebel NH, Ng VL, Baquero JER, Leung DH, Slowik V, Ovchinsky N, Shah AA, Arnon R, Miloh T, Gupta N, Mohammad S, Kogan-Liberman D, Squires JE, Sanchez MC, Hildreth A, Book L, Chu C, Alrabadi L, Azzam R, Chepuri B, Elisofon S, Falik R, Gallagher L, Kader H, Mogul D, Mujawar Q, Namjoshi SS, Valentino PL, Vitola B, Waheed N, Zheng MH, Lobritto S, Martinez M. Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Children With Liver Transplant and Native Liver Disease: An International Observational Registry Study. J Pediatr Gastroenterol Nutr 2021;72:807-14. [PMID: 33605666 DOI: 10.1097/MPG.0000000000003077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
58 Martinez MA, Franco S. Impact of COVID-19 in Liver Disease Progression. Hepatol Commun 2021. [PMID: 34222744 DOI: 10.1002/hep4.1745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Laurie K, Holcomb D, Kames J, Komar AA, DiCuccio M, Ibla JC, Kimchi-Sarfaty C. In Silico Evaluation of Cyclophilin Inhibitors as Potential Treatment for SARS-CoV-2. Open Forum Infect Dis 2021;8:ofab189. [PMID: 34109257 DOI: 10.1093/ofid/ofab189] [Reference Citation Analysis]
60 Elhence A, Vaishnav M, Biswas S, Chauhan A, Anand A, Shalimar. Coronavirus Disease-2019 (COVID-19) and the Liver. J Clin Transl Hepatol 2021;9:247-55. [PMID: 34007807 DOI: 10.14218/JCTH.2021.00006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Becchetti C, Gschwend SG, Dufour JF, Banz V. COVID-19 in Liver Transplant Recipients: A Systematic Review. J Clin Med 2021;10:4015. [PMID: 34501463 DOI: 10.3390/jcm10174015] [Reference Citation Analysis]
62 Campos-Varela I, Len O, Villagrasa A, Márquez-Algaba E, Esperalba J, Dopazo C, Los-Arcos I, Antón A, Castells L. Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort. Transpl Int 2021. [PMID: 34121244 DOI: 10.1111/tri.13946] [Reference Citation Analysis]
63 Zecher BF, Buescher G, Willemse J, Walmsley M, Taylor A, Leburgue A, Schramm C, Lohse AW, Sebode M. Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: A patient-oriented online survey. United European Gastroenterol J 2021. [PMID: 34105883 DOI: 10.1002/ueg2.12100] [Reference Citation Analysis]
64 Simon TG, Hagström H, Sharma R, Söderling J, Roelstraete B, Larsson E, Ludvigsson JF. Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study. BMC Gastroenterol 2021;21:439. [PMID: 34814851 DOI: 10.1186/s12876-021-02017-8] [Reference Citation Analysis]
65 Sivandzadeh GR, Askari H, Safarpour AR, Ejtehadi F, Raeis-Abdollahi E, Vaez Lari A, Abazari MF, Tarkesh F, Bagheri Lankarani K. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges. World J Clin Cases 2021; 9(22): 6178-6200 [PMID: 34434987 DOI: 10.12998/wjcc.v9.i22.6178] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Mani I, Alexopoulou A. Recent challenges facing patients with preexisting chronic liver disease in the era of the COVID-19 pandemic. Ann Gastroenterol 2021;34:625-33. [PMID: 34475732 DOI: 10.20524/aog.2021.0628] [Reference Citation Analysis]
67 Alfishawy M, Nso N, Nassar M, Ariyaratnam J, Bhuiyan S, Siddiqui RS, Li M, Chung H, Al Balakosy A, Alqassieh A, Fülöp T, Rizzo V, Daoud A, Soliman KM. Liver transplantation during global COVID-19 pandemic. World J Clin Cases 2021; 9(23): 6608-6623 [PMID: 34447809 DOI: 10.12998/wjcc.v9.i23.6608] [Reference Citation Analysis]
68 Goldman JD, Robinson PC, Uldrick TS, Ljungman P. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. J Immunother Cancer 2021;9:e002630. [PMID: 34117116 DOI: 10.1136/jitc-2021-002630] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Patel P, Pillai A. Liver Transplantation Services During the Time of COVID-19. J Clin Transl Hepatol 2021;9:587-91. [PMID: 34447689 DOI: 10.14218/JCTH.2021.00095] [Reference Citation Analysis]